Corobea Adelina Birceanu, Dumitru Adrian, Sajin Maria, Poenaru Radu, Puşcaşu Ana, Chirita Dragoş, Evsei Anca
Chirurgia (Bucur). 2017 Jul-Aug;112(4):477-481. doi: 10.21614/chirurgia.112.4.477.
Primary breast diffuse large B cell lymphoma (PBL) in male patients represents a rare clinical phenomenon and can imitate a breast carcinoma in its clinical presentation, so, therefore, the initial treatment for most patients remains surgery. Prompt diagnosis associating subsequent treatment combining chemotherapy and radiotherapy are of the utmost importance. We herein report a 56 years old male patient diagnosed with diffuse large B cell lymphoma, after clinically presenting with a visible tumor in the left breast and showing no axillary lymphadenopathy. Following clinical diagnosis we performed a breast biopsy with subsequent immunohistochemistry testing. The results showed that the malignant cells stained positive for CD 20, CD 10, and negative for BCL 2, myc and BCL 6, ER/PR with a high proliferation index (Ki 67 90%). The immunohistochemical tests were suggestive for primary large B cell lymphoma of the breast, germinal center type. The patient was submitted to three cycles of R-CHOP (cyclophosphamide, adryamicin, vincristine and prednisolone) and rituximab chemotherapy. Primary diffuse large B cell lymphoma is an extremely unique disease that involves a rather difficult differential diagnosis with a breast carcinoma. A strong index of clinical suspicion is necessary with early diagnosis and treatment.
男性原发性乳腺弥漫性大B细胞淋巴瘤(PBL)是一种罕见的临床现象,其临床表现可类似乳腺癌,因此大多数患者的初始治疗仍为手术。及时诊断并结合后续化疗和放疗的综合治疗至关重要。我们在此报告一名56岁男性患者,临床诊断为弥漫性大B细胞淋巴瘤,其左侧乳房出现可见肿物,且腋窝无淋巴结肿大。临床诊断后,我们进行了乳腺活检及后续免疫组化检测。结果显示,恶性细胞CD 20、CD 10染色呈阳性,BCL 2、myc和BCL 6、ER/PR染色呈阴性,增殖指数较高(Ki 67 90%)。免疫组化检测提示为乳腺原发性大B细胞淋巴瘤,生发中心型。该患者接受了三个周期的R-CHOP(环磷酰胺、阿霉素、长春新碱和泼尼松龙)及利妥昔单抗化疗。原发性弥漫性大B细胞淋巴瘤是一种极为独特的疾病,与乳腺癌的鉴别诊断相当困难。高度的临床怀疑指数对于早期诊断和治疗很有必要。